PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-08-05

Date Title Company
05-Aug-2021 Xeris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Highlights Businesswire
05-Aug-2021 Aldeyra Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Corporate Highlights Businesswire
05-Aug-2021 Bayer Strengthens Drug Discovery Platform Through Acquisition of Vividion Therapeutics Businesswire
05-Aug-2021 GCC Chemical Logistics Market Report 2021-2026 Featuring Agility Logistics, BDP International, and Talke Group - ResearchAndMarkets.com Businesswire
05-Aug-2021 Precision BioSciences to Report Second Quarter 2021 Financial Results on August 12, 2021 Businesswire
05-Aug-2021 Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks Businesswire
05-Aug-2021 Ironwood Pharmaceuticals Reports Strong Second-Quarter 2021 Results, Raises Full-Year Guidance Businesswire
05-Aug-2021 Enanta Pharmaceuticals Announces Nomination of Clinical Candidate EDP-235, its Lead Oral Protease Inhibitor Specifically Designed for the Treatment of COVID-19 Businesswire
05-Aug-2021 Exicure Provides Interim Results from Ongoing Phase 1b/2 Clinical Trial of Cavrotolimod (AST-008) Businesswire
05-Aug-2021 Clarity Pharma awarded Home Office Controlled Drugs license Clarity Pharma
05-Aug-2021 Bicycle Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update Businesswire
05-Aug-2021 NovaBay Pharmaceuticals to Hold Second Quarter 2021 Conference Call on August 12 Businesswire
05-Aug-2021 Global Recombinant Trypsin Powder Market 2021: Comprehensive Research, Key Tactics and Growth Projections by 2026 CDN Newswire
05-Aug-2021 Merck’s KEYTRUDA® (pembrolizumab) Significantly Prolonged Recurrence-Free Survival (RFS) Compared to Placebo as Adjuvant Therapy for Patients With Stage II Resected High-Risk Melanoma in Phase 3 KEYNOTE-716 Trial Businesswire
05-Aug-2021 Biocomposites presents STIMULAN® data at the MSIS 31st Annual Open Scientific Meeting 2021 Biocomposites
05-Aug-2021 Theragnostics Strengthens Board of Directors with Key Appointments Theragnostics
05-Aug-2021 AdaptHealth Corp. Announces Second Quarter 2021 Financial Results Businesswire
05-Aug-2021 Magellan Health Reports Second Quarter 2021 Financial Results Businesswire
05-Aug-2021 Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates Businesswire
05-Aug-2021 Nordic Nanovector Provides Update on PARADIGME, its Phase 2b Pivotal Trial with Betalutin® in R/R Follicular Lymphoma Nordic Nanovector